| Pharmaceutical active ingredients: |
| Palivizumab |
| Available forms, composition and doses of Synagis: |
| Injectable; Injection; Palivizumab 100 mgInjectable; Injection; Palivizumab 50 mg |
| Synagis medical category: |
| Human:Monoclonal antibodies |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J06BB16 - Palivizumab |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| AbbottMedimmuneThe Glory MedicinaZuellig Pharma |
| Related documents and information about Synagis: |
| Synagis prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Synacthene | Tetracosactide | Novartis; Institute of Pharmaceutical Research and Technology; Sigma-Tau Pharmaceuticals |
| Synacthene Retard | Tetracosactide; Zinc Chloride | Novartis; Institute of Pharmaceutical Research and Technology; Sigma-Tau Pharmaceuticals |
| Synadrenol | Metoprolol | Casa Keyerson |
| Synadrin | Prenylamine | Unidentified Pharmaceutical Company |
| Syn-A-Gen | Nonoxynol 9 | Democal; Vifor Pharma |
| Synalar | Fluocinolone Acetonide | Medicis Pharmaceutical Corporation; AFT Pharmaceuticals; Agencia Lei Va Hong; Astellas Pharma; AstraZeneca; Bioglan; Biomed, Singapore; Derma UK; DKSH; Edward Keller; Grunenthal; Janssen; Jolly Jatel Laboratoire; Minerva Pharmaceutical; Pharmed Import & Export; Sanofi-Aventis; Syntex; United Italian Trading; V.J. Bartlett; Valeo Pharma; Ventiv Health Magyarorszag; Yamanouchi |
| Synalar + DBO | Broxyquinoline; Fluocinolone Acetonide | Medicis Pharmaceutical Corporation; Roche; Syntex |
| Synalar Bi-Ophtalmic | Fluocinolone Acetonide; Neomycin Sulfate; Polymyxin B Sulfate | Medicis Pharmaceutical Corporation; GlaxoSmithKline |
| Synalar Bi-Otic | Fluocinolone Acetonide; Neomycin Sulfate; Polymyxin B Sulfate | Medicis Pharmaceutical Corporation |
| Synalar C | Clioquinol; Fluocinolone Acetonide | Medicis Pharmaceutical Corporation; Bioglan; Biomed, Singapore; Derma UK; Pharmed Import & Export; Syntex; VJ Bartlett |